Related references
Note: Only part of the references are listed.Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme
Albert Lai et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Carmustine Wafers (Gliadel) Plus Concomitant Temozolomide Therapy After Resection of Malignant Astrocytoma: Growing Evidence for Safety and Efficacy
Matthew J. McGirt et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Irradiation of the potential cancer stem cell niches in the adult brain improves progression-free survival of patients with malignant glioma
Patrick Evers et al.
BMC CANCER (2010)
Feasibility and safety of GliaSite brachytherapy in treatment of CNS tumors following neurosurgical resection
A. Gabriella Wernicke et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2010)
Hypofractionated Stereotactic Radiation Therapy: An Effective Therapy for Recurrent High-Grade Gliomas
Shannon E. Fogh et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Vaccine provides new hope for patients with deadly brain cancer
[Anonymous]
FUTURE NEUROLOGY (2010)
Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide
Gregor Dresemann et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Safety and efficacy of erlotinib in first-relapse glioblastoma: a phase II open-label study
W. K. Alfred Yung et al.
NEURO-ONCOLOGY (2010)
Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma
John H. Sampson et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
Henry S. Friedman et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
Teri N. Kreisl et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Salvage reirradiation for recurrent glioblastoma with radiosurgery: radiographic response and improved survival
Mehul Patel et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME
et al.
NEUROSURGERY (2009)
Postoperative treatment of primary glioblastoma multiforme with radiation and concomitant temozolomide in elderly patients
Stephanie E. Combs et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Resection and survival in glioblastoma multiforme: An RTOG recursive partitioning analysis of ALA study patients
Uwe Pichlmeier et al.
NEURO-ONCOLOGY (2008)
Clinical course of high-grade glioma patients with a biopsy-only surgical approach:: a need for individualised treatment
C. Balana et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2007)
Genetic pathways to primary and secondary glioblastoma
Hiroko Ohgaki et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial
W Stummer et al.
LANCET ONCOLOGY (2006)
Diagnosis and treatment of recurrent high-grade astrocytoma
NA Butowski et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Gliadel® wafer in initial surgery for malignant glioma:: long-term follow-up of a multicenter controlled trial
M Westphal et al.
ACTA NEUROCHIRURGICA (2006)
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
HS Phillips et al.
CANCER CELL (2006)
The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma
MN Tsao et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: A north central cancer treatment group study
E Galanis et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
One week on/one week off:: A novel active regimen of temozolomide for recurrent glioblastoma
W Wick et al.
NEUROLOGY (2004)
Volume of residual disease as a predictor of outcome in adult patients with recurrent supratentorial glioblastomas multiforme who are undergoing chemotherapy
GE Keles et al.
JOURNAL OF NEUROSURGERY (2004)
A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival
M Lacroix et al.
JOURNAL OF NEUROSURGERY (2001)
Share Paper
